CORC  > 复旦大学上海医学院
A phase I dose escalation study of Nimotuzumab in combination with concurrent chemoradiation for patients with locally advanced squamous cell carcinoma of esophagus
Zhao, Kuai-le; Hu, Xi-chun; Wu, Xiang-hua; Fu, Xiao-long; Fan, Min; Jiang, Guo-Liang
刊名INVESTIGATIONAL NEW DRUGS
2012
卷号30期号:4
关键词Nimotuzumab Esophageal carcinoma Chemoradiation
ISSN号0167-6997
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4910280
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Zhao, Kuai-le,Hu, Xi-chun,Wu, Xiang-hua,et al. A phase I dose escalation study of Nimotuzumab in combination with concurrent chemoradiation for patients with locally advanced squamous cell carcinoma of esophagus[J]. INVESTIGATIONAL NEW DRUGS,2012,30(4).
APA Zhao, Kuai-le,Hu, Xi-chun,Wu, Xiang-hua,Fu, Xiao-long,Fan, Min,&Jiang, Guo-Liang.(2012).A phase I dose escalation study of Nimotuzumab in combination with concurrent chemoradiation for patients with locally advanced squamous cell carcinoma of esophagus.INVESTIGATIONAL NEW DRUGS,30(4).
MLA Zhao, Kuai-le,et al."A phase I dose escalation study of Nimotuzumab in combination with concurrent chemoradiation for patients with locally advanced squamous cell carcinoma of esophagus".INVESTIGATIONAL NEW DRUGS 30.4(2012).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace